Patient Guide: Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 300 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04524611
Status: ACTIVE_NOT_RECRUITING
Condition: Crohn's Disease (CD)
Phase: PHASE3

Where You Can Participate

This study is available at 300 locations across the country.

Top locations include:
  • • Chandler, Arizona
  • • Coronado, California
  • • Irvine, California
  • • And 297 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Join Clinical Trial NCTNCT04524611

How to Join This Clinical Trial - NCTNCT04524611

Learn how to participate in this PHASE3 trial studying an investigational therapy for Crohn's Disease (CD). Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Crohn's Disease (CD). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Crohn's Disease (CD)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04524611 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 300 locations. Find a study site near you:

Clinical Research Site

Chandler, Arizona 85224-1636 - United States

Status: Contact for availability

Clinical Research Site

Coronado, California 92118-1408 - United States

Status: Contact for availability

Clinical Research Site

Irvine, California 92618 - United States

Status: Contact for availability

Clinical Research Site

Los Alamitos, California 90720-3309 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90048 - United States

Status: Contact for availability

Clinical Research Site

Sacramento, California 95817 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94158 - United States

Status: Contact for availability

Clinical Research Site

Danbury, Connecticut 06810 - United States

Status: Contact for availability

Clinical Research Site

Hamden, Connecticut 06518 - United States

Status: Contact for availability

Clinical Research Site

New Haven, Connecticut 06510 - United States

Status: Contact for availability

And 290 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Crohn's Disease (CD):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships